DexCom (DXCM) PT Raised to $157 at Piper Jaffray
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $90.79 +2.29%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Join SI Premium – FREE
Piper Jaffray analyst JP McKim raised the price target on DexCom (NASDAQ: DXCM) to $157.00 (from $150.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at H.C. Wainwright
- WaterBridge Infrastructure (WBI) PT Raised to $40 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
